In vitro susceptibilities of clinical yeast isolates to the new antifungal eberconazole compared with their susceptibilities to clotrimazole and ketoconazole

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 5, 1999, Pages 1258-1259

  Torres Rodríguez, Josep M ^a   Mendez, Raúl ^a   López Jodra, Olga ^a   Morera, Yolanda ^a   Espasa, Mateu ^a   Jimenez, Teresa ^a   Lagunas, Carme ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLOTRIMAZOLE; EBERCONAZOLE; KETOCONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; CRYPTOCOCCUS NEOFORMANS; DRUG SENSITIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; YEAST;

EID: 0344654915     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.5.1258     Document Type: Article

References (11)

1. del Palacio, A., S. Cuetara, and A. R. Noriega. 1995. Topical treatment of tinea corporis and tinea cruris with eberconazole (WAS 2160) cream 1% and 2%: a phase II dose-finding pilot study. Mycoses 38:317-324.
2. Espinel-Ingroff, A., L. Steel-Moore, V. G. Bruzzese, et al. 1994. Evaluation of two growth control dilution for the determination of 90% (MIC-90%) and 80% (MIC-80%) inhibition fluconazole MIC endpoints. Diagn. Microbiol. Infect. Dis. 20:81-86.
3. Font, E., J. Freixes, and J. Julve, 1995. Profile of a new topical antimycotic, eberconazole. Rev. Iberoam. Micol. 12:16-17.
4. Madrenys-Brunet, N., J. M. Torres-Rudríguez, and A. Urrea-Arbelaez. 1996. Estudio epidemiológico de las micosis ungueales en Barcelona. Rev. Iberoam. Micol. 12:320.
5. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing for yeast. Approved standard M27-A. National Committee for Clinical Laboratory Standards, Villanova, Pa.
6. Odds, F. C. 1993. Resistance of yeast to azole-derivate antifungals. J. Antimicrob. Chemother. 31:436-471.
7. Pfaller, M. A. 1995. Epidemiology of candidiasis. J. Hosp. Infect. 30:329-338.
8. Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1996. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39:1-8.
9. Rodero, L., M. Boutureira, W. Vivot, C. Canteros, D. Perrota, and G. Davel. 1996. Candidiasis orofaríngea en pacientes HIV positivos: perfil de resistencia a antifúngicos. Rev. Iberoam. Micol. 13:64-67.
10. Rodriguez-Tudela, J. L., and J. V. Martinez-Suarez. 1994. Improved medium for fluconazole susceptibility testing of Candida albicans. Antimicrob. Agents Chemother. 38:4-5.
11. Torres-Rodriguez, J. M., A. Carrillo, C. Gallach, N. Madrenys, and J. Julve. 1988. In vitro activity of WAS 2160 and WAS 2163, two new antifungal agents compared with clotrimazole and bifonazole for yeast and dermatophytes. Rev. Iberoam. Micol. 6(Suppl. 1):84.